04Participate in discussions with prospective partners and contribute to the preparation of meeting materials and minutes
05Coordinate the preparation and execution of confidentiality agreements and support the exchange of information throughout assessment processes
06Collaborate closely with regional commercial, business insights and finance teams to gather and validate key business assumptions
07Prepare structured analyses and clear recommendations to support decision-making by management and key stakeholders
08Contribute to the continuous improvement of business development assessment tools and processes
Anforderungen
↳Currently pursuing a Master-s degree in Business Administration, Economics, Finance, or a related field, which includes a mandatory 4 to 6-month internship formalized through a tripartite agreement with your university
↳Strong analytical skills with an interest in business development and international markets
↳Strong command of Excel, including advanced functions and data modelling, as well as PowerPoint for the preparation of impactful presentations
↳Fluent in English, preferably with a good working knowledge of French
Vorteile
＋Gain hands-on experience in international business development and strategic partnership activities within the pharmaceutical industry
＋Develop strong analytical skills and strengthen your ability to synthesize complex information and formulate clear, data-driven recommendations to support strategic decision-making
＋Collaborate with cross-functional teams, including regional commercial, business insights and finance colleagues, and interact with external partners worldwide
＋Bring your ideas to life in a collaborative and supportive environment that values creativity, initiative and continuous improvement
＋Learn from a team of experts who will share their knowledge and support your professional growth
Technologien
05
ExcelPowerPoint
Unternehmen
06
OM Pharma SA
Biopharmaceuticals
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases. It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections. The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.
